BioSpace News Archive

Packaging of pharmaceutical products is considered to be a very crucial element for the pharmaceutical industry because such packaging ensures the quality and safety of drugs that it contains.

The global hemoglobin A1c testing devices market is estimated to register growth at a CAGR of 10.7% during the forecast period from 2019 to 2027.

Swedish Orphan Biovitrum AB announced its report for the second quarter of 2022

Antengene Corporation Limited today announced that it has entered into a pre-clinical research collaboration with Celularity Inc.

The Validation Institute, a third-party professional community that validates health care providers delivering superior results, has certified that patients who underwent Regenexx regenerative orthobiologic procedures to treat joint problems lower costs by avoiding surgery with excellent outcomes.

OneOncology, the platform for independent community oncology practices, announced the formation of five OneOncology Disease Groups.

Sage Therapeutics, Inc., a biopharmaceutical company leading the way to create a world with better brain health, announced that it will host a live webcast on Tuesday, August 2, 2022 at 8:00 a.m. ET to announce second quarter 2022 financial results and discuss recent business updates.

Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today announced that the U.S. Food and Drug Administration (FDA) has granted tentative approval to LUMRYZ, also known as FT218.

XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announces submission of a request for “scientific advice review” to the European Medicines Agency (the “EMA”) and more specifically the Committee for Medicinal Products for Human Use (the “CHMP”) regarding the XRx-008 program.

Endotronix, Inc. announced plans to relocate and expand their headquarters in Naperville, Illinois to support the full U.S. commercial launch of its Cordella™ Heart Failure System and Pulmonary Artery Sensor, pending pre-market approval of the sensor by the U.S. Food & Drug Administration.